Skip to content

the effect of saffron on depression

Comparison the effect of 40mg and 80mg hydro-alcoholic extract of saffron in the treatment of mild to moderate depressed patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201204049371N1
Enrollment
60
Registered
2013-03-06
Start date
2011-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder. Mild depressive episode- Moderate depressive episode

Interventions

Intervention 1: first group: cap fluoxetine 30 mg/day with cap hidroalcoholic extract of saffron 40 mg bid for 4 weeks. Intervention 2: Second group: cap fluoxetine 30 mg/day with cap hidroalcoholic e
Treatment - Drugs
first group: cap fluoxetine 30 mg/day with cap hidroalcoholic extract of saffron 40 mg bid for 4 weeks
Second group: cap fluoxetine 30 mg/day with cap hidroalcoholic extract of saffron 80 mg bid for 4 weeks

Sponsors

Research comittee of Mazandaran university of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age range between 20 to 50 years; absence of psychosis; absence of manic episodes or BMD; negative history of mental retardation;negative history of general medical condition; negative history of drug dependency; nagative history of antidepressant drug use four weeks before study; Psychotherapic treatment simultaneously. exclusion criteria: pregnancy; risk of suicide.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of depression. Timepoint: first, 14th and 28th day of treatment. Method of measurement: Hamilton Deoression scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Amini

Psychiatric and behavioral research center of Mazandaran University of Medical Sciences

r.mamini@mazums.ac.irmojg.am@gmail.com+98 15 1328 5659

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026